This new 165-page report from Venture Planning Group contains 14 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC abused drugs market.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
Review of three POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
Five-year test volume and reagent sales forecasts for drugs of abuse procedures by market segment:
Physician Offices/Group Practices
Ambulatory Care Centers
Analysis of drugs of abuse procedures
Assessments of major POC suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Specific opportunities for new instruments and reagent systems with potentially significant market appeal during the next five years.
Design criteria for POC testing products.
Alternative business expansion strategies.
Potential market entry barriers and risks.
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group's proprietary data files.
SIMILAR MARKET STUDIES
This 111-page report reviews current instrumentation technologies, and compares features of leading blood banking automated and semi-automated analyzers.The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 111 pages
March 2017 | $0 | View Details >>
According to Stratistics MRC, the Global Hemoglobinopathie market is accounted for $4.6 billion in 2015 and is expected to reach $8.99 billion by 2022 growing at a CAGR of 10.0% from 2015 to 2022. Increasing incidences of hemoglobin disorders with strong product portfolio for sickle cell anemia such as HQK-1001 ...
September 2016 | $4150 | View Details >>
This report studies sales (consumption) of Dialysis Services in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Asahi KASEI Medical DaVita Healthcare Partners Diaverum Fresenius Medical ...
July 2016 | $4900 | View Details >>
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. "2015-2019 Future Horizons and Growth Strategies in the European Clinical Chemistry and Immunodiagnostics Market” is a new five-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends ...
August 2015 | $12800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research